Inovio Pharmaceuticals Inc. closed 86.91% short of its 52-week high of $14.75, which the company reached on April 1st.

Inovio (INO) announced promising interim results from an ongoing Phase 1 proof-of-concept trial evaluating DMAbs for COVID-19. In the trial, ...

Inovio Pharmaceuticals Inc. closed 86.10% short of its 52-week high of $14.75, which the company achieved on April 1st.

PLYMOUTH MEETING, PA, USA I March 13, 2025 I INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help ...

The Global Inhaled Nitric Oxide Market is valued at approximately USD 1.12 billion in 2023 and is projected to experience robust growth with a compound annual growth rate (CAGR) of more than 7.70% ...

INO-3107 works by inducing T cell responses against HPV-6 and HPV-11, the viruses responsible for RRP, and has shown potential in preventing or slowing the growth of new papillomas. The trial's ...

Alex Jones, the founder of Infowars, said one of his reporters, Jamie White was killed in Austin. Police later confirmed his identity.

A downtrend has been apparent in Inovio Pharmaceuticals (INO) lately. While the stock has lost 13.2% over the past two weeks, it could witness a trend reversal as a hammer chart pattern was formed ...

Poster will describe loss of detectable HPV-6 in Recurrent Respiratory Papillomatosis patients following treatment with INO-3107 PLYMOUTH MEETING, Pa., Feb. 10, 2025 /PRNewswire/ -- INOVIO (NASDAQ ...

Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting ...